NATERA
Natera specializes in cell-free DNA testing is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing.
NATERA
Industry:
Biotechnology Genetics Health Diagnostics Medical
Founded:
2004-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.natera.com
Total Employee:
1001+
Status:
Active
Contact:
650-249-9090
Total Funding:
409.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Current Advisors List
Board_member
2007-01-01
Board_observer
2008-04-01
Board_member
2019-08-01
Current Employees Featured
Matthew Rabinowitz CEO @ Natera
CEO
2005-06-01
Ravi Mhatre Investor @ Natera
Investor
2008-04-01
Jonathan Sheena Founder & CTO @ Natera
Founder & CTO
2005-08-01
Solomon Moshkevich General Manager (GM), Oncology @ Natera
General Manager (GM), Oncology
2020-02-01
Steve Chapman CEO @ Natera
CEO
2019-01-01
Paul Billings Chief Medical Officer @ Natera
Chief Medical Officer
2018-01-01
Helen Wang Manager, Technical Product Manager @ Natera
Manager, Technical Product Manager
2021-07-01
Styrmir Sigurjonsson Vice President, Statistics @ Natera
Vice President, Statistics
Agust Egilsson Head of AI Research @ Natera
Head of AI Research
2020-04-01
Asaf Sadowsky Director, Product Management @ Natera
Director, Product Management
2021-08-01
Founder
Stock Details
Investors List
Roelof Botha
Roelof Botha investment in Post-IPO Equity - Natera
Matthew Rabinowitz
Matthew Rabinowitz investment in Post-IPO Equity - Natera
HealthCor Partners
HealthCor Partners investment in Series F - Natera
Sequoia Capital
Sequoia Capital investment in Series F - Natera
Sofinnova Investments
Sofinnova Investments investment in Series F - Natera
RA Capital Management
RA Capital Management investment in Series F - Natera
OrbiMed
OrbiMed investment in Series F - Natera
Franklin Templeton Investments
Franklin Templeton Investments investment in Series F - Natera
Jennison Associates
Jennison Associates investment in Series F - Natera
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Natera
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-21 | Myome | Natera investment in Series B - Myome | 23 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-24 | Natera Appoints Minetta Liu, M.D. as Chief Medical Officer of Oncology |
Official Site Inspections
http://www.natera.com Semrush global rank: 84.85 K Semrush visits lastest month: 1.24 M
- Host name: server-3-171-85-116.iad89.r.cloudfront.net
- IP address: 3.171.85.116
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Natera"
Leadership Team - Natera
Phil Grinnell is the chief sales officer at Natera, where he oversees the strategy and continued growth of the sales organization across the company. In this role, he leads the U.S. sales …See details»
Natera: A global leader in cell-free DNA testing
Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care.See details»
Natera - Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tu…See details»
Natera, Inc. | Investor Relations
3 days ago Natera™ is a global leader in cell-free DNA (cfDNA) testing with a focus on women’s health, oncology, and organ health. Our cutting-edge cfDNA technology platform combines novel molecular biology techniques with …See details»
Natera - Crunchbase Company Profile & Funding
Natera specializes in cell-free DNA testing and is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. …See details»
Org Chart Natera - The Official Board
The organizational chart of Natera displays its 48 main executives including Steve Chapman, Mike Brophy and Robert Schueren. Toggle navigation The Official Board. Search. Search. …See details»
Governance Documents - Natera, Inc.
At Natera Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by …See details»
Natera - Leadership Team - The Org
The Leadership Team at Natera is responsible for directing the company’s strategic vision and operational execution across its diverse clinical offerings. Comprising top executives from various functional areas, including …See details»
Natera - The Org
Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology. Where some set out to build a test, they set out to achieve a mission: change the management of …See details»
Natera - LinkedIn
Natera | 170,917 followers on LinkedIn. We are a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. | Natera™ is a global leader in cell ...See details»
Natera - isuog.org
Natera provides advanced DNA technology that enables transplant providers to deliver quality, personalized care. As a diagnostics company with proprietary bioinformatics and molecular …See details»
Natera's Corporate Mission and Vision
Feb 7, 2020 The post Interview with Erika Hanson Brown, founder of the patient leader community COLONTOWN appeared first on Natera. Next Video How can Signatera be …See details»
Natera, Inc. | Natera CEO Steve Chapman Recognized as a 2024 …
Jan 17, 2025 Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its CEO, Steve Chapman, has been selected as one of the top …See details»
Natera: Culture - LinkedIn
Natera | 160,536 followers on LinkedIn. We are a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. | Natera™ is a global leader in cell ...See details»
Our Technology - Natera
Natera's cutting edge technology platform combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of …See details»
Here’s What Lifted Natera (NTRA) in Q4 and 2024 - Yahoo Finance
6 days ago "Natera, Inc. (NASDAQ:NTRA), an industry leader in genetic testing for women’s health and cancer recurrence monitoring, reported robust financial results for the third quarter …See details»
Natera, Inc. | Natera's Signatera® Test Selected for NRG …
Pivotal clinical trial aims to establish a new standard of care for stage II and III colon cancer patients Natera, Inc. (NASDAQ: NTRA) a leader in transforming care through genetic and cell …See details»
Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of …
Mar 17, 2025 Natera generated total revenues of $476 mn in 4Q24, compared to $311 mn in 4Q23, translating into an impressive increase of 53.0%, outpacing the testing volume growth …See details»
Natera Reports Fourth Quarter and Full Year 2024 Financial Results
Dec 31, 2024 AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth …See details»
Natera, Inc. | Natera Announces Innovation Roadmap, with …
Jan 15, 2025 AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at …See details»